Patent 7858788 was granted and assigned to Shionogi on December, 2010 by the United States Patent and Trademark Office.
Is to provide a novel compound having an anti-viral activity, particularly a HIV integrase inhibitory activity, and an agent, particularly an anti-HIV agent.